Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
104,849,534
-
Total 13F shares
-
71,059,216
-
Share change
-
+2,402,809
-
Total reported value
-
$8,477,596,090
-
Put/Call ratio
-
84%
-
Price per share
-
$119.19
-
Number of holders
-
359
-
Value change
-
+$290,725,751
-
Number of buys
-
205
-
Number of sells
-
140
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2019
As of 31 Mar 2019,
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by
359 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
71,059,216 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., SANDS CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., STATE STREET CORP, FIL Ltd, and Avoro Capital Advisors LLC.
This page lists
359
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.